Tag: shahnawaz amdani

22-CHP-3075509-CQD-650×450-Amdani
September 26, 2023/Pediatrics/Cardiology

A New Metric for Donor-Recipient Size Matching in Pediatric Heart Transplantation?

Findings from more than 7,500 donor-recipient pairs

23-CHP-3783528 CQD Amdani – Perspectives Article
May 15, 2023/Pediatrics/Cardiology

Perspective: Large-Scale Studies Are Needed To Address Pediatric Heart Failure

Pediatric heart failure and transplant cardiologist discusses his research approach

22-CHP-3480260 CQD Amdani-Race and Socioeconomic
April 6, 2023/Pediatrics/Cardiology

Digging Deeper into Racial and Socioeconomic Disparities in Pediatric Heart Transplant

More scientific evidence is needed to guide these challenging, complex decisions

22-CHP-3075509-CQD-650×450-Amdani
January 9, 2023/Pediatrics/Cardiology

Heart Transplant Outcomes Are Improving, Except in Children With Myocarditis

Study shows waitlist and post-transplant outcomes haven’t improved in 30 years

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-Child-ICU-465125303
May 10, 2022/Pediatrics/Cardiology

Study Reveals Burden of Pediatric Heart Failure in the United States

Authors find the higher death rates in children compared with adults with heart failure 'disturbing'

20-HRT-005-cardiac-surgery-650×450
November 1, 2021/Pediatrics/Cardiology

Identifying Risk and Improving Access to Transplant in Children With End-Stage Heart Failure

Outcomes research designed to identify risk and disparities in pediatric heart transplant patients

Mom and daughter visit doctor during COVID-10 pandemic
September 7, 2021/Pediatrics

Racial and Ethnic Disparities Persist in Pediatric Heart Transplantation

Differences still exist, particularly in waitlist mortality

21-CHP-2303160-Hero-650×450
September 2, 2021/Pediatrics/Cardiology

Pediatric Waitlist and Heart Transplant Mortality Rates Similar in All Cardiomyopathy Phenotypes

VADs remain underutilized in non-dilated cardiomyopathy patients

BackPage 1 of 2Next
Advertisement
Ad